Mbx Biosciences, Inc. · NASDAQ:MBX
Azoulay Salomon sold 231 Mbx Biosciences, Inc. shares (Form 4)
Traded May 6, 2026 · Filed May 8, 2026
On May 6, 2026, Azoulay Salomon (Chief Medical Officer) sold 231 Mbx Biosciences, Inc. shares at US$29.54 for US$6,824, leaving 14,769 shares. Filed May 8, 2026 (Form 4).
- Sold
- 231 shares
- Price
- US$29.54
- Value
- US$6,824
- Holding after
- 14,769 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 6, 2026 | Common Stock | Sale | 231 | US$29.54 | 14,769 | Direct |
Source
Related
- Mbx Biosciences, Inc.
- Azoulay Salomon
- Mbx Biosciences, Inc. shareholders
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Azoulay Salomon · May 11, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Smither John W · Aug 4, 2026
- Form 4 · Hoerter Steven L. · Aug 4, 2026